StockWatch
·
IDFC FIRST BANK LTD · QQ2 FY-2027 · THE CALL

Strong growth masked by treasury volatility; NIM pressure near-term

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

Q2 FY27 resultsIDFCFIRSTBIDFC First Bank Ltd30 Oct 2026 · 6 min read
Verdict

Hold

confidence 7/10

Credibility

Grade B

Met credit cost & revenue guidance; opex growth 15% vs 13-14% guided. NIM guidance (5.8% FY27) at risk near-term.

Short-term outlook

Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

Core operating momentum intact (OPM +290 bps YoY, opex leverage improving) but near-term NIM pressure from FCNR mobilization and excess liquidity drags reported profitability. PAT growth of 202% inflated by treasury variance, not core business. ROA on track ~1% if NIM recovers as guided; key risk is if deposit mix-driven margin compression persists beyond Q3.

₹11923.3 Cr

Revenue · +20% YoY

₹1049.2 Cr

Reported PAT · +201.7% YoY

Expanding

Margins · vs guidance: Mixed

Did the claims hold up?

Management's claims vs. the numbers

Core PAT crossed INR1,000 crore for second consecutive quarter

MET

Delivered PAT ₹1,049.2 Cr; core PAT (ex-treasury) approximately ₹1,036 Cr per mgmt

Operating profit up 38.5% YoY, margin expanding

MET

OPM improved from ~18.5% (prior year Q2) to 21.4% (Q2 FY27), +290 bps YoY

Loan growth 30.1% YoY including FCNR

MISS

Revenue growth only 20% YoY despite 30% loan growth; non-loan segments or rates lagging

NIM moderating due to FCNR, liquidity, asset mix; expect recovery to 5.8%

OVERSTATED

NIM under pressure in Q2; FY27 5.8% guidance at risk unless sharp recovery in Q3-Q4

Credit cost improving, 1.38% in Q2 vs 1.53% Q1

MET

1.38% is within 1.5%-1.6% guidance; improvement validated

Opex growth 15% YoY

OVERSTATED

Opex INR5,942 Cr, 16% YoY growth per call; exceeds prior 13-14% guidance

ROA on trajectory for ~1% full year

MET

Q2 annualized ROA ~0.99%, claim credible but tight margin vs 1% target

QoQ PAT marginally down due to treasury income variance

MET

QoQ PAT -8.6%; treasury income fell from INR181 Cr (Q1) to INR11 Cr (Q2); explains gap

Earnings quality

What changed since the last call

Deltas vs. the prior call

FCNR deposit mobilization scale

New

₹34,400 Cr raised (10% of deposits); not flagged in prior guidance. Strategic win but creates 16 bps NIM headwind Q2.

NIM guidance trajectory revised down near-term

Downgrade

FY27 5.8% target still held, but Q2 reality shows 32 bps headwinds vs implicit Q1 baseline. Recovery to 5.8% now seen as Q3-Q4 event, not steady-state.

Opex growth expectation raised

Downgrade

15% YoY growth in Q2 vs 13-14% prior guidance. Attributed to branch expansion & tech, managed within overall CIR bridge.

Asset quality trajectory remains on track

Neutral

GNPA improved 19 bps to 1.32% (from 1.51% Q1). No change to 1.5%-1.6% credit cost guidance. Macro watch remains cautious (El Niño, drought).

Deposit franchise strength validated

Upgrade

CASA deposits ₹1.66L Cr growing 19.8% YoY, above loan growth pace. Demonstrates funding stability & optionality for future FCNR-like moves.

ROA trajectory confidence reaffirmed

Maintained

Annualized Q2 ROA ~0.99%, on path to ~1% FY27 target. Management cites operating leverage, margin expansion, reduced credit costs.

The Q&A

Moderate analyst pushback on NIM, FCNR cost transparency, opex growth, and asset quality in drought areas. Management held firm on guidance trajectory while acknowledging timing headwinds. No evasion on Q2 misses (QoQ PAT, opex guidance) — attributed to temporary factors.

The exchanges that mattered

FCNR cost-of-funds impact — Akshay Jain, Autonomous

Answered

FCNR cost ~6.86% vs ~7.45%-7.50% domestic; 40-60 bps benefit net of hedging. But FCNR lend rates tied to IBU, creating 16 bps NIM headwind on portfolio mix. Offset by 1% benefit on cost of capital & no PSL requirement.

Deposit LDR and growth cadence — Jai Prakash Mundhra, ICICI Securities

Partial

Deposits expected to grow ahead of loans. FCNR inflows managed to preserve LDR. Estimate Q3-Q4 normalization at 115%-116% LCR (vs Sept 139% due to excess liquidity parking).

NIM bridge and 55% cost-to-income path — Param Subramanian, Investec

Partial

Incremental cost-to-income ratio for H1 is 55%, validating path. Assumes 20% both loan and deposit growth, modest repo hikes (25 bps more priced in), NIM recovery to 5.8%. Managing quarter-to-quarter, but fundamentals support trajectory.

Asset quality & El Niño impact — Param Subramanian, Investec

Answered

No pressure yet. Cautious on 2-3 drought-affected states; expect reasonable numbers couple of quarters. Definitely comfortable with 1.5%-1.6% guidance. Watch rural portfolio, but delinquency low.

CASA growth and structuring — Piran Engineer, CITIC Securities

Answered

CASA averaging ~30% YoY growth, down to 23% this quarter. Not structural decline, just scale normalization. Target: keep CASA in high 40s% of deposits. No plan to sacrifice CASA for fixed deposits.

Corporate banking economics — Piran Engineer, CITIC Securities

Answered

Corporate cost-to-income ~32%-33%, yield ~9.2%. Retail CIR higher but customer quality strong. Corporate book 76% A/above-rated, zero delinquency 7 years. ROA differential driven by credit cost & speed of decision-making.

Insurance circular (IRDAI) impact — Abhishek Murarka, HSBC

Dodged

Insurance commission change in consultation phase; full impact likely FY28+. Estimated impact material but offset by rate hikes (25 bps done, 25 more expected), FCNR benefit (~100 bps), and opex leverage. Not building conservatism, not optimistic.

Treasury income volatility — Multiple (implied in Q&A flow)

Partial

Q2 treasury modest (₹11 Cr) vs ₹181 Cr Q1. No expectation of repeating Q1 levels. Focused on core operating momentum, not trading P&L.

Funding cost and FY28 guidance — Akshay Jain, Autonomous

Partial

Off-the-cuff: FY28 COF 3-5 bps higher YoY, assuming continued rate hikes & FCNR repricing. Not a formal guidance, but indicates modest headwind.

Guidance

Forward guidance and management's confidence

FY27 loan growth 20%+, deposit growth 20%+

High

Q2 validates: loans +30.1% YoY (excl FCNR +22.2%), deposits +25.9% YoY. Trajectory intact.

FY27 revenue growth tracking 20%+ momentum

High

Q2 FY27 +20% YoY. H1 NII +5.7%, fee +24.5%. Organic momentum strong.

FY27 NIM 5.8% (from 5.75% prior)

Medium

Q2 under pressure (32 bps headwind). Recovery expected Q3-Q4 as FCNR normalizes, repo stabilizes. Achievable but timing risk.

FY27 cost-to-income targeting 55% by FY28

High

Q2 incremental CIR 55% (H1 70.2% blended). Path validated via 500 bps opex-income differential management.

Operating leverage expansion to 38%+ operating profit growth

High

Q2 opex growth 15% YoY vs income growth 21% YoY. Incremental CIR 55% validates path.

Branch expansion & tech capex supporting 20%+ growth

Medium

Capex embedded in opex growth (15% YoY). No separate capex guidance; tech & infra treated as operating.

Risks the call surfaced

Ranked by how much they should concern a holder

NIM compression

Medium

FCNR deposits grew to ₹34,400 Cr, creating 16 bps NIM drag. If deposit mix stays skewed toward FCNR/low-cost bulk, NIM recovery to 5.8% delayed or incomplete.

Macro headwinds (asset quality)

Medium

Management flagged El Niño and drought concern for H2. Rural portfolio concentrated in lenders' books; some states showing pressure. If agricultural stress spreads, credit costs could rise above 1.5%-1.6% guidance.

Opex growth acceleration

Low

Opex grew 15% YoY vs 13-14% prior guidance. Branch expansion, tech stack, and digital capex higher than modeled. Could constrain 55% CIR target if opex growth doesn't moderate.

Funding cost trajectory

Medium

Management assumes 25 bps repo hike already done, another 25 bps possible by year-end. FCNR deposits assumed to reprice higher as rates rise. If yield pricing (customer-facing rates) lags liability cost increases, NIM margin erodes further.

Regulatory risk (insurance commission)

Low

IRDAI issued consultation paper on insurance commission caps & structure. Full impact expected FY28+. Could reduce insurance fee income materially; timing and scope uncertain.

Management

Score 8/10. Clear, granular disclosure on NIM bridge (32 bps breakdown by factor), FCNR cost structure, and forward CIR path. Transparent on guidance gaps (opex vs prior, NIM timing). Some evasion on IRDAI impact scale and treasury normalization. Delivered H1 revenue +18% YoY, meeting 20%+ loan/deposit growth targets. Opex growth at 15% exceeds 13-14% guidance; asset quality improved; credit cost beat guidance. Track record credible.

What to watch next
  • 1 · Q3/Q4 FY27

    NIM recovery as FCNR deposits normalize, excess liquidity deploys, repo rates stabilize

  • 2 · FY28

    Cost-to-income ratio trending to 55% target via opex control + income leverage

  • 3 · H2 FY27

    Insurance regulatory circular impact (IRDAI commission change) implementation & mitigation

ROA on track ~1% if NIM recovers as guided; key risk is if deposit mix-driven margin compression persists beyond Q3.

Informational and educational content only. Not investment advice.